Dugald Seely, ND, FABNO, founding director of the Ottawa Integrative Cancer Centre (OICC) talks about past research and future plans for research in naturopathic oncology.
Dugald Seely, ND, MSc, FABNO, leads the clinical practice and cancer research agenda for the Ottawa Integrative Cancer Centre. In addition to his clinical role as a naturopathic doctor, he also serves as the director of research and clinical epidemiology at the Canadian College of Naturopathic Medicine, affiliate investigator for the Ottawa Hospital Research Institute, and peer reviewer for Health Canada’s Canadian Adverse Reaction Newsletter. As founder of the OICC, Seely is pioneering a contemporary cancer treatment model based on scientifically grounded, evidence-informed complementary medicine. With the establishment of the first integrative cancer centre in Eastern Canada, Seely and his team are addressing research gaps in whole-systems of cancer care. Seely completed his master of science in cancer research at the University of Toronto and is active in the exploration of complementary therapies with a primary clinical and academic focus in the area of integrative oncology. He is also an active clinician and Fellow of the American Board of Naturopathic Oncology (FABNO). Awarded competitive grant and trainee funding from CIHR, the SickKids Foundation, and the Lotte and John Hecht Memorial Foundation, Seely is the principal investigator for a number of clinical trials and synthesis projects. He strongly believes in the ability of evidence-based medicine to effect change in the healthcare system. As an educator, researcher, clinician, and frequent speaker at conferences around the world, Seely is seeking to help shift the debate and help move toward a more whole-person cancer care model that is espoused by integrative oncology.